ST6GALNAC2 and breast cancer: Although sialyl-Tn is associated with a poor outcome for breast cancer [51,87,88,89], ST6GalNAc2 was identified as a metastasis suppressor of breast cancer by in vivo RNA interference (RNAi) screen combined with next-generation sequencing [90].